Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00484_DB00780_nanopub.RAestswhOuTNd5ftdDglVt4B5vKc5vhu9wlzLq8l0MSLI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00484_DB00780 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00484_DB00780 label "DDI between Brimonidine and Phenelzine - MAO Inhibitors like phenelzine may enhance the hypertensive effect of Alpha2-Agonists (Ophthalmic). The concomitant use of monoamine oxidase inhibitors and ophthalmic alpha2 agonists is contraindicated. [drugbank_resource:DB00484_DB00780]" assertion.
- drugbank_resource:DB00484_DB00780 identifier "drugbank_resource:DB00484_DB00780" assertion.
- drugbank_resource:DB00484_DB00780 title "DDI between Brimonidine and Phenelzine - MAO Inhibitors like phenelzine may enhance the hypertensive effect of Alpha2-Agonists (Ophthalmic). The concomitant use of monoamine oxidase inhibitors and ophthalmic alpha2 agonists is contraindicated." assertion.
- drugbank:DB00484 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00484_DB00780 assertion.
- drugbank:DB00780 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00484_DB00780 assertion.